Ireland
--:--IST
Recruiting Not applicable

Efficacy of Electric Fans in Children During Heat Waves

NCT07864103 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-10-02
Last updated
2026-10-07

Condition(s) studied

Heat StressPhysiological StressChild Development

Investigational drug(s) / intervention(s)

Simulated exposure to indoor overheating without fansSimulated exposure to indoor overheating with fans

Simulated exposure to indoor overheating without fans: Children and young adults exposed to a 6-hour simulated heat exposure without fans.

Simulated exposure to indoor overheating with fans: Children and young adults exposed to a 6-hour simulated heat exposure without fans.

Study summary

Extreme heat exposure is an escalating global public health concern, with climate change driving increases in the frequency, duration, and intensity of heat events. Projections indicate substantial increases in heat-related morbidity and mortality in the coming decades, including among children and youth, who are increasingly recognized as a physiologically vulnerable population. The purpose of this project is to evaluate the effectiveness of commonly used heat-mitigation strategies, specifically midday access daylong electric fan use, in reducing physiological strain and maintaining cognitive function, perceptual comfort, and psychological well-being in children and youth exposed to prolonged indoor heat. The study also aims to determine whether these strategies provide comparable protection in children and youth relative to young adults. Participants will complete four sessions under the same environmental conditions (31°C and 36°C), with each temperature completed twice: once with continuous electric fan use and once without fan use. The four sessions therefore consist of: (1) 31°C without fan use; (2) 31°C with fan use; (3) 36°C without fan use; and (4) 36°C with fan use.

Eligibility

Sex
ALL
Min age
9 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants must be healthy males or females within the specified age ranges (9-12 years, 13-16 years, or 20-25 years). * All participants must be habitually active, defined as participation in regular physical activity at least three times per week for a minimum of 20 minutes per session over the previous six months. * Participants must be able to understand and communicate in English or French. * For participants under 18 years of age, written parental or guardian consent and participant assent will be required prior to participation. Exclusion Criteria: * Individuals will be excluded from participation if they have any acute illness at the time of testing (e.g., cold, flu, or infection), or a history of chronic medical conditions that may affect thermoregulation, cardiovascular function, or exercise capacity, including but not limited to cardiovascular, metabolic, respiratory, or neurological disorders. Individuals taking medications known to influence thermoregulation, hydration status, or cardiovascular responses will also be excluded. * Participants with a history of heat-related illness (e.g., heat exhaustion or heat stroke) will not be eligible. * Individuals with digestive abnormalities or gastrointestinal conditions that may contraindicate ingestion of a telemetry pill will also be excluded. * Any individual who, in the opinion of the investigators, may be at increased risk or unable to safely complete the study procedures will be excluded.

Primary outcome measure(s)

  • Core temperature (Peak) during daylong exposure to indoor overheating — End of 6 hour daylong exposure
    Peak core (indexed by visceral temperature) temperature (15 min average) during exposure. Visceral temperature is measured continuously throughout the 6 hour exposure to the simulated indoor overheating.

Trial sites (1)

FacilityCityRegionStatus
University of Ottawa Ottawa Ontario Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07864103 on ClinicalTrials.gov ↗ ← All trials in Canada